Cargando…
1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial
BACKGROUND: Fever and neutropenia (FN) are frequent complications in children with cancer who receive chemotherapy. Although there is evidence of the efficacy of outpatient treatment, inpatient treatment is the standard of care in Mexico City. We aimed to determine whether sequential parenteral-oral...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252742/ http://dx.doi.org/10.1093/ofid/ofy210.1605 |
_version_ | 1783373333990998016 |
---|---|
author | Avilés, Martha Zapata, Marta Rosales, Rómulo Otero, Francisco Valencia, Amilcar Peñaloza, Jose Reyes-Lopez, Alfonso |
author_facet | Avilés, Martha Zapata, Marta Rosales, Rómulo Otero, Francisco Valencia, Amilcar Peñaloza, Jose Reyes-Lopez, Alfonso |
author_sort | Avilés, Martha |
collection | PubMed |
description | BACKGROUND: Fever and neutropenia (FN) are frequent complications in children with cancer who receive chemotherapy. Although there is evidence of the efficacy of outpatient treatment, inpatient treatment is the standard of care in Mexico City. We aimed to determine whether sequential parenteral-oral outpatient treatment is non-inferior to intravenous inpatient treatment for children with FN in a middle-income setting. METHODS: Randomized controlled clinical trial in subjects 1 to 18 years old with low-risk FN in three hospitals in Mexico City. After 48 to 72 hours of cefepime inpatient treatment, subjects were eligible to participate if they were afebrile for at least 24 hours, had negative cultures and no source of infection. Subjects were randomly assigned to either continue receiving cefepime (inpatient arm) or start receiving cefixime (outpatient arm). Primary end point was treatment failure define as new onset fever, new source of infection or necessity of change antibiotic. Estimated sample size was 68 FN episodes per group. Parametric and nonparametric statistical analyses were performed for comparisons between groups. RESULTS: Between July 2015 and September 2017, a total of 1,237 episodes of FN were evaluated, of which 469 episodes were eligible. From these, 388 were excluded: 337 due to not meeting the inclusion criteria, eight parents refused to participate, four were evaluated after 72 hours of treatment and three were excluded for other reasons. Of the 117 randomized episodes, 59 were allocated into the outpatient arm and 58 into the inpatient arm. After randomization, demographic and clinical variables did not differ between groups. Treatment failure occurred in 6.9% (4) of patients in the inpatient arm vs. 0% in the outpatient arm (P = 0.05). Failures were associated to influenza B infection, catheter related blood stream infection and fever without a source. Mean duration of antibiotics was 4.6 days [SD (standard deviation) 4.5 days, C.I. 95% 3.5–5.8 days] in the outpatient arm and 4.4 days (SD 2.5 days, CI 95%, 3.7–5.0 days) in the inpatient arm (P = 0.70). CONCLUSION: In our population, outpatient sequential, parenteral-oral treatment with cefixime seems to be as safe and efficacious as parenteral inpatient treatment of low-risk FN episodes. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6252742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62527422018-11-28 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial Avilés, Martha Zapata, Marta Rosales, Rómulo Otero, Francisco Valencia, Amilcar Peñaloza, Jose Reyes-Lopez, Alfonso Open Forum Infect Dis Abstracts BACKGROUND: Fever and neutropenia (FN) are frequent complications in children with cancer who receive chemotherapy. Although there is evidence of the efficacy of outpatient treatment, inpatient treatment is the standard of care in Mexico City. We aimed to determine whether sequential parenteral-oral outpatient treatment is non-inferior to intravenous inpatient treatment for children with FN in a middle-income setting. METHODS: Randomized controlled clinical trial in subjects 1 to 18 years old with low-risk FN in three hospitals in Mexico City. After 48 to 72 hours of cefepime inpatient treatment, subjects were eligible to participate if they were afebrile for at least 24 hours, had negative cultures and no source of infection. Subjects were randomly assigned to either continue receiving cefepime (inpatient arm) or start receiving cefixime (outpatient arm). Primary end point was treatment failure define as new onset fever, new source of infection or necessity of change antibiotic. Estimated sample size was 68 FN episodes per group. Parametric and nonparametric statistical analyses were performed for comparisons between groups. RESULTS: Between July 2015 and September 2017, a total of 1,237 episodes of FN were evaluated, of which 469 episodes were eligible. From these, 388 were excluded: 337 due to not meeting the inclusion criteria, eight parents refused to participate, four were evaluated after 72 hours of treatment and three were excluded for other reasons. Of the 117 randomized episodes, 59 were allocated into the outpatient arm and 58 into the inpatient arm. After randomization, demographic and clinical variables did not differ between groups. Treatment failure occurred in 6.9% (4) of patients in the inpatient arm vs. 0% in the outpatient arm (P = 0.05). Failures were associated to influenza B infection, catheter related blood stream infection and fever without a source. Mean duration of antibiotics was 4.6 days [SD (standard deviation) 4.5 days, C.I. 95% 3.5–5.8 days] in the outpatient arm and 4.4 days (SD 2.5 days, CI 95%, 3.7–5.0 days) in the inpatient arm (P = 0.70). CONCLUSION: In our population, outpatient sequential, parenteral-oral treatment with cefixime seems to be as safe and efficacious as parenteral inpatient treatment of low-risk FN episodes. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6252742/ http://dx.doi.org/10.1093/ofid/ofy210.1605 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Avilés, Martha Zapata, Marta Rosales, Rómulo Otero, Francisco Valencia, Amilcar Peñaloza, Jose Reyes-Lopez, Alfonso 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial |
title | 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial |
title_full | 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial |
title_fullStr | 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial |
title_full_unstemmed | 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial |
title_short | 1949. Safety and Efficacy of Ambulatory Outpatient Treatment of Febrile Neutropenia in Children With Cancer in Mexico: A Multicenter Randomized Controlled Trial |
title_sort | 1949. safety and efficacy of ambulatory outpatient treatment of febrile neutropenia in children with cancer in mexico: a multicenter randomized controlled trial |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252742/ http://dx.doi.org/10.1093/ofid/ofy210.1605 |
work_keys_str_mv | AT avilesmartha 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial AT zapatamarta 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial AT rosalesromulo 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial AT oterofrancisco 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial AT valenciaamilcar 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial AT penalozajose 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial AT reyeslopezalfonso 1949safetyandefficacyofambulatoryoutpatienttreatmentoffebrileneutropeniainchildrenwithcancerinmexicoamulticenterrandomizedcontrolledtrial |